Systemic therapy for metastatic colorectal cancer: Patterns of chemotherapy and biologic therapy use in US medical oncology practice

Journal of Oncology Practice

Volumn 6, Issue 6, 2010, Pages 301-307

  Hess, Gregory P ^a   Wang, Peter Feng ^a   Quach, David ^a   Barber, Beth ^a   Zhao, Zhongyun ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CANCER COMBINATION CHEMOTHERAPY; COLORECTAL CANCER; DRUG DOSE ESCALATION; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; METASTASIS; UNITED STATES;

EID: 79952419581     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2010.000072     Document Type: Article

References (16)

1. Goldberg RM, Rothenberg ML, Van Cutsem E, et al: The continuum of care: A paradigm for the management of metastatic colorectal cancer. Oncologist 12:38-50, 2007 (Pubitemid 46143501)
2. Gruenberger T, Schuell B, Puhalla H, et al: Changes in liver surgery for colorectal cancer liver metastases under neoadjuvant treatment strategies. Eur J Surg 36:317-321, 2004 (Pubitemid 40292338)
3. Falcone A, Fornaro L, Loupakis F, et al: Optimal approach to potentially resectable liver metastases from colorectal cancer. Expert Rev Anticancer Ther 8:1533-1539, 2008
4. Tournigand C, André T, Achille E, et al: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 22:229-237, 2004 (Pubitemid 41095086)
5. Kelly H, Goldberg RM: Systemic therapy for metastatic colorectal cancer: Current options, current evidence. J Clin Oncol 23:4553-4560, 2005 (Pubitemid 46196586)
6. Meyerhardt JA, Mayer RJ: Systemic therapy for colorectal cancer. N Engl J Med 352:476-487, 2005
7. Board RE, Valle JW: Metastatic colorectal cancer: Current systemic treatment options. Drugs 67:1851-1867, 2007
8. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Colon Cancer version 4.2008. http://www.nccn.org/professionals/ physician-gls/PDF/colon.pdf Accessed December 13, 2008
9. Grothey A, Sugrue MM, Purdie DM, et al: Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: Results from a large observational cohort study (BRiTE). J Clin Oncol 26:5326-5334, 2008
10. Kopetz S, Abbruzzese JL: Hidden biases in an observational study of bevacizumab beyond progression. J Clin Oncol 27:1732, 2009
11. Clark JW, Grothey A: Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations. http://www.uptodate.com/patients/ content/topic.do?topicKey=~Y.HUfE6yXpcXADM. Accessed December 15, 2008
12. Goldberg RM: Therapy for metastatic colorectal cancer. Oncologist 11:981-987, 2006
13. VARIAN Medical Systems: ARIA Oncology Information System. www.varian.com/us/oncology/radiation-oncology/aria/ Accessed December 12, 2008
14. IMPAC Software: The Elektra Group Medical Oncology EMR. www.impac.com/productsNEW/medical-oncology/index.html Accessed December 12, 2008
15. American Joint Committee on Cancer: Colon and rectum, in: Greene FL (ed), AJCC Cancer Staging Manual, 6th ed. New York: Springer; pp 113-124, 2002
16. Cooper GS, Kou TD, Reynolds HL Jr: Receipt of guideline-recommended follow-up in older colorectal cancer survivors: A population-based analysis. Cancer 113:2029-2037, 2008